Patterns of Recurrence After Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

被引：0
|
作者：
Onal, Cem [1 ]
Guler, Ozan Cem [1 ]
Oymak, Ezgi [2 ]
机构：
[1] Baskent Univ, Fac Med, Adana Dr Turgut Noyan Res & Treatment Ctr, Dept Radiat Oncol, Adana, Turkey
[2] Iskenderun Gelisim Hosp, Div Radiat Oncol, Antakya, Turkey
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 110卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcomes of metastasis-directed treatment of bone oligometastatic disease in prostate cancer
    Rogowski, P.
    Schmidt-Hegemann, N.
    Trapp, C.
    Shi, R.
    von Bestenbostel, R.
    Ma, J.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S751 - S752
  • [32] The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
    Sutera, Philip
    Phillips, Ryan M.
    Deek, Matthew
    Ozyigit, Gokhan
    Onal, Cem
    Tran, Phuoc T.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 339 - 341
  • [33] Re: Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 200 (02): : 245 - 246
  • [34] Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial
    Ost, Piet
    Reynders, Dries
    Decaestecker, Karel
    Fonteyne, Valerie
    Lumen, Nicolaas
    De Bruycker, Aurelie
    Lambert, Bieke
    Delrue, Louke
    Bultijnck, Renee
    Goetghebeur, Els
    Villeirs, Geert
    De Man, Kathia
    Ameye, Filip
    Billiet, Ignace
    Joniau, Steven
    Vanhaverbeke, Friedl
    de Meerleer, Gert
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] The efficacy of metastasis-directed radiation therapy (MDRT) for oligometastatic castration-resistant prostate cancer (CRPC)
    Nagahara, Akira
    Kanaki, Tomohiro
    Yamamoto, Akinaru
    Yamamoto, Yoshiyuki
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Konishi, Koji
    Teshima, Teruki
    Nishimura, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [36] Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease
    Nicholls, L.
    Chapman, E.
    Khoo, V
    Suh, Y-E
    Tunariu, N.
    Wang, Y.
    van As, N.
    CLINICAL ONCOLOGY, 2022, 34 (01) : 63 - 69
  • [37] Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center
    Mueller, Peter J.
    Dietlein, Markus
    Kobe, Carsten
    Heidenreich, Axel
    Drzezga, Alexander
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (04): : 314 - 324
  • [38] Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer
    Imber, Brandon S.
    Varghese, Melissa
    Goldman, Debra A.
    Zhang, Zhigang
    Gewanter, Richard
    Marciscano, Ariel E.
    Mychalczak, Borys
    Gorovets, Daniel
    Kollmeier, Marisa
    McBride, Sean M.
    Zelefsky, Michael J.
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) : 1213 - 1224
  • [39] Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?
    Chen, Jonathan J.
    Weg, Emily
    Liao, Jay J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 163 - 176
  • [40] Cost-effectiveness of metastasis-directed therapy in the setting of oligometastatic hormone-sensitive prostate cancer.
    Parikh, Neil Rohit
    Nickols, Nicholas George
    Rettig, Matthew
    King, Christopher R.
    Raldow, Ann C.
    Steinberg, Michael L.
    Tran, Phuoc T.
    Kishan, Amar Upadhyaya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345